290 related articles for article (PubMed ID: 28751561)
21. BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia.
Raess PW; Mintzer D; Husson M; Nakashima MO; Morrissette JJ; Daber R; Bagg A
Blood; 2013 Oct; 122(17):3084-5. PubMed ID: 24159168
[No Abstract] [Full Text] [Related]
22. The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Zamò A; van den Brand M; Climent F; de Leval L; Dirnhofer S; Leoncini L; Ng SB; Ondrejka SL; Quintanilla-Martinez L; Soma L; Wotherspoon A
Virchows Arch; 2023 Sep; 483(3):317-331. PubMed ID: 37656249
[TBL] [Abstract][Full Text] [Related]
23. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
[TBL] [Abstract][Full Text] [Related]
24. Splenic marginal zone lymphoma.
Piris MA; Onaindía A; Mollejo M
Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
[TBL] [Abstract][Full Text] [Related]
25. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene.
Mateo MS; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Leukemia; 2001 Apr; 15(4):628-34. PubMed ID: 11368366
[TBL] [Abstract][Full Text] [Related]
26. Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features.
Kanellis G; Mollejo M; Montes-Moreno S; Rodriguez-Pinilla SM; Cigudosa JC; Algara P; Montalban C; Matutes E; Wotherspoon A; Piris MA
Haematologica; 2010 Jul; 95(7):1122-9. PubMed ID: 20220064
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological analysis of splenic red pulp low-grade B-cell lymphoma.
Suzuki T; Miyoshi H; Shimono J; Kawamoto K; Arakawa F; Furuta T; Yamada K; Yanagida E; Takeuchi M; Seto M; Sone H; Takizawa J; Ohshima K
Pathol Int; 2020 May; 70(5):280-286. PubMed ID: 32052529
[TBL] [Abstract][Full Text] [Related]
28. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
29. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
[TBL] [Abstract][Full Text] [Related]
30. The role of splenectomy in management of splenic B-cell lymphomas.
Archibald WJ; Baran AM; Williams AM; Salloum RM; Richard Burack W; Evans AG; Syposs CR; Zent CS
Leuk Res; 2023 May; 128():107053. PubMed ID: 36906942
[TBL] [Abstract][Full Text] [Related]
31. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
32. The genetics of nodal marginal zone lymphoma.
Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D
Blood; 2016 Sep; 128(10):1362-73. PubMed ID: 27335277
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.
Arribas AJ; Rinaldi A; Mensah AA; Kwee I; Cascione L; Robles EF; Martinez-Climent JA; Oscier D; Arcaini L; Baldini L; Marasca R; Thieblemont C; Briere J; Forconi F; Zamò A; Bonifacio M; Mollejo M; Facchetti F; Dirnhofer S; Ponzoni M; Bhagat G; Piris MA; Gaidano G; Zucca E; Rossi D; Bertoni F
Blood; 2015 Mar; 125(12):1922-31. PubMed ID: 25612624
[TBL] [Abstract][Full Text] [Related]
34. Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin.
Baldini L; Fracchiolla NS; Cro LM; Trecca D; Romitti L; Polli E; Maiolo AT; Neri A
Blood; 1994 Jul; 84(1):270-8. PubMed ID: 8018922
[TBL] [Abstract][Full Text] [Related]
35. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?
Mollejo M; Algara P; Mateo MS; Sánchez-Beato M; Lloret E; Medina MT; Piris MA
Histopathology; 2002 Jan; 40(1):22-30. PubMed ID: 11903595
[TBL] [Abstract][Full Text] [Related]
36. First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in CXCR4 and TRAF3 genes.
Zheng S; Lin L; Jin J; Liu F; Wei J; Feng Y; Zhang Y; Luo H; Qin J; Feng W
Int J Hematol; 2023 Sep; 118(3):394-399. PubMed ID: 36935465
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings.
Behdad A; Bailey NG
Arch Pathol Lab Med; 2014 Oct; 138(10):1295-301. PubMed ID: 25268192
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow and splenic histology in hairy cell leukaemia.
Wotherspoon A; Attygalle A; Mendes LS
Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898
[TBL] [Abstract][Full Text] [Related]
40. Unraveling the genetics of transformed splenic marginal zone lymphoma.
Grau M; López C; Navarro A; Frigola G; Nadeu F; Clot G; Bastidas-Mora G; Alcoceba M; Baptista MJ; Blanes M; Colomer D; Costa D; Domingo-Domènech E; Enjuanes A; Escoda L; Forcada P; Giné E; Lopez-Guerra M; Ramón O; Rivas-Delgado A; Vicente Folch L; Wotherspoon A; Climent F; Campo E; López-Guillermo A; Matutes E; Beà S
Blood Adv; 2023 Jul; 7(14):3695-3709. PubMed ID: 36995085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]